Report - 1. INDICATIONS AND USAGE 2. DOSAGE AND ADMINISTRATION · 2.4 Dosage in Relapsed Multiple Myeloma and Relapsed Mantle Cell Lymphoma Bortezomib Teva (1.3 mg/m 2 /dose) is administered

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form